Clinical Trials Browser

Phase 2 × Carcinoma, Adenoid Cystic × regorafenib × Clear all

NCT02098538 2025-09-10

Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma

Phase 2 Completed

38 enrolled 10 charts

Carcinoma, Adenoid Cystic